6. Assessment of consistency of the treatment effect with respect to lymph nodal status.
Lymph nodal status | |||
Negative HR (95% CI) |
Positive HR (95% CI) |
RHR (95% CI) | |
BCIRG006 | 0.32 (0.17 to 0.62) | 0.68 (0.52 to 0.86) | 0.47 (0.23 to 0.94) |
B31+N9831 | 0.47 (0.04 to 5.22) | 0.48 (0.39 to 0.59)* | 0.98 (0.09 to 11.23) |
HERA | 0.59 (0.39 to 0.91) | 0.63 (0.51 to 0.78)* | 0.94 (0.58 to 1.52) |
NOAH | 0.35 (0.09 to 1.29) | 0.62 (0.39 to 0.98) | 0.57 (0.14 to 2.32) |
Summary | 0.74 (0.51 to 1.08) |
Q = 2.74 (dof = 3); P = 0.434; I2 = 0
* The hazard ratios (HRs) were obtained by pooling the HRs reported by the authors at different cut‐points CI: confidence interval RHR: ratios of HR